EU Commission head says AstraZeneca contract contains binding orders

BERLIN, Jan 29 (Reuters) - The European Union’s contract with AstraZeneca for its COVID-19 vaccine contains binding orders, EU Commision Head Ursula von der Leyen said on Friday, demanding a plausible explanation from the drugmaker for delivery hold-ups.

Von der Leyen told Deutschlandfunk radio the best-effort delivery cause in the contract was only valid as long as it was not clear whether AstraZeneca could develop a vaccine.

She said the contract contained very clear delivery amounts for December and the first three quarters of 2021, and also mentioned four production sites, two of which are in Britain.

“There are binding orders and the contract is crystal clear,” she said. (Reporting by Caroline Copley; editing by Thomas Seythal)